The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 28, 2014
Filed:
Jul. 29, 2013
Applicant:
Gilead Sciences, Inc., Foster City, CA (US);
Inventors:
Terrence C. Dahl, Sunnyvale, CA (US);
Mark M. Menning, San Francisco, CA (US);
Reza Oliyai, Burlingame, CA (US);
Taiyin Yang, Monte Sereno, CA (US);
Assignee:
Gilead Sciences, Inc., Foster City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61J 3/00 (2006.01); A61K 31/675 (2006.01); A61K 31/513 (2006.01); A61K 9/20 (2006.01); A61K 9/24 (2006.01); A61K 31/535 (2006.01); A61K 9/16 (2006.01);
U.S. Cl.
CPC ...
A61J 3/00 (2013.01); A61K 31/675 (2013.01); A61K 31/513 (2013.01); A61K 9/2077 (2013.01); A61K 9/2095 (2013.01); A61K 9/209 (2013.01); A61K 9/1694 (2013.01); A61K 31/535 (2013.01);
Abstract
This invention is directed to a composition comprising dry granulated tenofovir DF and emtricitabine, and a method for making same. Dry granulation was unexpectedly found to be important in preparing a tenofovir DF containing composition suitable for inclusion in a combination dosage form containing emtricitabine, efavirenz and tenofovir DF.